Featured Research

from universities, journals, and other organizations

Doing A Spin With DNA

Date:
April 17, 2005
Source:
Netherlands Organization For Scientific Research
Summary:
A Dutch led international team of researchers has unravelled how nature releases the torque built up in DNA at the molecular level. The researchers from Delft University of Technology, the Ecole Normale Supérieure in Paris and the Sloan-Kettering institute in New York published their findings in the 31 March 2005 issue of Nature.

A topoisomerase IB enzyme clamps onto a DNA molecule. The enzyme cuts through one of the two strands after which the DNA molecule can spin around in a cavity of the enzyme. (Illustration TUDelft/Tremani)

DNA consists of two long strands joined together by pairs of bases. Both strands wind around each other in the form of a double helix with the base pairs acting as the 'stairs' in a staircase. The sequence of these base pairs stores genetic information. During cell division genetic material is copied and the enzymes responsible for this must be able to transcribe the base sequences. This is only possible if the portion of DNA to be transcribed is unwound. This winding and unwinding of the DNA gives rise to torsional forces in the DNA, the magnitude of which increases as cell division progresses. These forces can delay the process of cell division and under certain conditions even stop it. Topoisomerase IB can reduce these torsional forces.

The enzyme releases the torsion from the DNA as follows: The enzyme surrounds the double-stranded DNA like a clamp and then temporarily cuts through one of the two DNA strands. The accumulated torsional forces in the DNA are then spun out around the intact strand. After a number of turns the topoisomerase ones again firmly grabs the spinning DNA and 'glues' (ligates) the broken stands neatly back together again. The researchers were able to determine the exact number of turns removed by the topisomerase between 'cutting' and 'gluing'.

The precise mechanism of topoisomerase IB is also important for cancer research. Drugs which inhibit the functioning of topoisomerase IB are already in clinical use, but can possibly be improved using the knowledge from this study.


Story Source:

The above story is based on materials provided by Netherlands Organization For Scientific Research. Note: Materials may be edited for content and length.


Cite This Page:

Netherlands Organization For Scientific Research. "Doing A Spin With DNA." ScienceDaily. ScienceDaily, 17 April 2005. <www.sciencedaily.com/releases/2005/04/050414173542.htm>.
Netherlands Organization For Scientific Research. (2005, April 17). Doing A Spin With DNA. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2005/04/050414173542.htm
Netherlands Organization For Scientific Research. "Doing A Spin With DNA." ScienceDaily. www.sciencedaily.com/releases/2005/04/050414173542.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins